我国医药企业上市融资现状分析和策略探究.docVIP

我国医药企业上市融资现状分析和策略探究 目录 摘要 1 前言 3 第一章 导论 4 1.1研究背景及意义 4 1.2研究方法 5 1.3研究思路与逻辑结构 5 第二章 企业融资理论 7 2.1融资方式分类与比较 7 2.2上市融资概念及分类 8 第三章 我国医药企业融资特点及融资方式 9 3.1我国医药企业融资特点 9 3.2股票上市融资中股票的发行类型 10 3.3我国医药企业IPO上市融资 11 3.4我国已上市医药企业的融资方式分析 14 第四章 政策建议与上市融资策略选择 15 4.1政策建议 15 4.2上市途径选择 16 4.3总结 18 参考文献 19 致谢 21 我国医药企业上市融资现状分析和策略探究 摘要：我国的医药企业具有高投入、高风险、高回报的特征，这使得医药企业可选的融资集相对受限，然而资本市场的发展为我国医药企业提供了重要的融资渠道。为促进医药企业充分利用资本市场这一融资窗口，研究医药企业上市融资的可行性和有效性显得十分必要。本文着重分析我国医药企业上市融资方式，并以定性分析法、归纳演绎分析法、比较分析法、实证分析与规范分析相结合的方法从医药企业的IPO融资方式和已上市医药企业的融资方式两个角度分析了我国医药企业上市融资存在的问题及其原因，并给出相关建议及上市融资途径选择策略，建议医药企业在选择股票上市筹集资金时要根据自身状况和需求，权衡成本收益，选择合适的上市融资途径，另外医药上市企业还必须完善公司治理结构，提高资金使用效率。 关键词：医药企业；上市融资；IPO融资；股权偏好；现状；策略 The Status and Strategy of Chinese Pharmaceutical enterprises’ Public Financing Abstract: With the features of high input, high risk and high return ,Chinese pharmaceutical enterprises only have relatively limited options to financing. However, the development of capital market provides an important channel for Chinas pharmaceutical industries’ financing progress. Therefore, it is necessary to explore public financing methods for china’s pharmaceutical companies to take full advantage of the developing capital market. with a combination of such a few methods as qualitative analysis , induction and deduction, comparison, empirical and normative analysis, this paper focuses on the status of the pharmaceutical companies’ financing progress from two aspects: one is concerning about the IPO financing method, the other is about listed pharmaceutical companies’ refinancing method. Meanwhile, it gives suggestions and strategies to related companies, and finally comes to a conclusion that china’s pharmaceutical companies ,when raising funds by IPO, should weigh the costs and benefits ,and select the appropriate means of financing on the bases of their own situation and demand. Besides, the listed pharmaceutical companies should better the management structure and use the capital to its fullest. Keyword: Pharmaceutical